EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors

EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors

Abstract Background The objective of this study was to investigate real-world EGFR mutation testing in patients with metastatic non-small cell lung cancer (NSCLC) upon progression on first−/second-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI), and subsequent tre...

Full description

Bibliographic Details
Main Authors: Anne C. Chiang, Ancilla W. Fernandes, Melissa Pavilack, Jennifer W. Wu, François Laliberté, Mei Sheng Duh, Nabil Chehab, Janakiraman Subramanian
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Cancer
Subjects:
NSCLC
EGFR-TKI
Real-world
EGFR mutation testing
Treatment patterns
Online Access:http://link.springer.com/article/10.1186/s12885-020-06826-0

Internet

http://link.springer.com/article/10.1186/s12885-020-06826-0

Similar Items